The vectors have efficiently prevented a full-blown AMD phenotype in AMD models and are currently tested in clinical trials: (1) the small soluble fms-like tyrosine kinase-1 (sFlt-1. The gene discussed is FLT1; the disease is age-related macular degeneration.